Cancer Center Research

In This Section


Hematology Oncology Publications

Dr. Vincent Armenio

Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancer.
Vergote IB, Garcia A, Micha J, Pippitt C, Bendell J, Spitz D, Reed N, Dark G, Fracasso PM, Ibrahim EN, Armenio VA, Duska L, Poole C, Gennigens C, Dirix LY, Leung AC, Zhao C, Soufi-Mahjoubi R, Rustin G.
J Clin Oncol. 2013 Nov 10;31(32):4060-6. PMID: 24081946

Dr. Mohsin Malik

Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis.
Malik MI, Litzow M, Hogan W, Patnaik M, Murad MH, Prokop LJ, Winters JL, Hashmi S.
Blood Res. 2014 Jun;49(2):100-6. PMID: 25025011

Dr. Bharti Rathore

Merkel cell carcinoma of the lower extremity: a case report.
Roda DJ, Albano B, Rathore B, Zhou L.
J Am Podiatr Med Assoc. 2014 Jul;104(4):422-5. PMID: 25076088

Hodgkin's lymphoma therapy: past, present, and future.
Rathore B, Kadin ME.
Expert Opin Pharmacother. 2010 Dec;11(17):2891-906. PMID: 21050034

Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93).
Rathore R, Birnbaum A, Rathore B, DiPetrillo T, Kennedy T, Ready N.
Cancer Chemother Pharmacol. 2010 Nov;66(6):1013-7. PMID: 20130878

Dr. Ritesh Rathore

Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting
Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response.
Junghans RP, Ma Q, Rathore R, Gomes EM, Bais AJ, Lo AS, Abedi M, Davies RA, Cabral HJ, Al-Homsi AS, Cohen SI.
Prostate. 2016 Oct;76(14):1257-70. PMID: 2732474

Phase I Study of Anti-CD3 x Anti-Her2 Bispecific Antibody in Metastatic Castrate Resistant Prostate Cancer Patients.
Vaishampayan U, Thakur A, Rathore R, Kouttab N, Lum LG.
Prostate Cancer. 2015;2015:285193. PMID: 25802762

Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial.
Lum LG, Thakur A, Al-Kadhimi Z, Colvin GA, Cummings FJ, Legare RD, Dizon DS, Kouttab N, Maizel A, Colaiace W, Liu Q, Rathore R.
Clin Cancer Res. 2015 May 15;21(10):2305-14. PMID: 25688159

Multiple infusions of CD20-targeted T cells and low-dose IL-2 after SCT for high-risk non-Hodgkin's lymphoma: a pilot study.
Lum LG, Thakur A, Pray C, Kouttab N, Abedi M, Deol A, Colaiace WM, Rathore R.

Bone Marrow Transplant. 2014 Jan;49(1):73-9. PMID: 24056738

Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a survival analysis of a Brown University Oncology Group phase II study.
Birnbaum A, Dipetrillo T, Rathore R, Merriam P, Wanebo H, Thomas A, Puthawala Y, Joyce D, Luppe
D, Khurshid H, Follett N, Sio TT, Safran H.

Am J Clin Oncol. 2014 Apr;37(2):162-6. PMID: 23275269

Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck.
Ready NE, Rathore R, Johnson TT, Nadeem A, Chougule P, Ruhl C, Radie-Keane K, Theall K, Wanebo HJ, Marcello J, Kennedy T.
Am J Clin Oncol. 2012 Feb;35(1):6-12. PMID: 21293244

Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies.
Wanebo HJ, Rathore R, Chougule P, DiSiena MR, Koness RJ, McRae RG, Nigri PT, Radie-Keane K, Ready N.
Ann Surg Oncol. 2011 Nov;18(12):3479-85. PMID: 21553142

Dr. Todd Roberts

A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.
Miller KB, Roberts TF, Chan G, Schenkein DP, Lawrence D, Sprague K, Gorgun G, Relias V, Grodman H, Mahajan A, Foss FM.
Bone Marrow Transplant. 2004 May;33(9):881-9. PMID: 14990986

Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease.
Alcindor T, Gorgun G, Miller KB, Roberts TF, Sprague K, Schenkein DP, Foss FM.
Blood. 2001 Sep 1;98(5):1622-5. PMID: 11520818

Hyperleukocytosis during induction therapy with arsenic trioxide for relapsed acute promyelocytic leukemia associated with central nervous system infarction.
Roberts TF, Sprague K, Schenkein D, Miller KB, Relias V.
Blood. 2000 Dec 1;96(12):4000-1. PMID: 11186272

Dr. Joseph Sweeney

Effect of ADAMTS13 activity turnaround time on plasma utilization for suspected thrombotic thrombocytopenic purpura.
Connell NT, Cheves T, Sweeney JD.
Transfusion. 2016 Feb;56(2):354-9.  PMID: 26456149

Discriminating different causes of transfusion-associated pulmonary edema.
Nixon CP, Sweeney JD.
Transfusion. 2015 Aug;55(8):1825-8. PMID: 26264120

Discriminating different causes of transfusion-associated pulmonary edema.
Nixon CP, Sweeney JD.
Transfusion. 2015 Aug;55(8):1825-8. PMID: 26264120

Aggregates in platelet concentrates.
van der Meer PF, Dumont LJ, Lozano M, Bondar N, Wong J, Ismay S, Pink J, Nussbaumer W, Coene J, Feys HB, Compernolle V, Devine DV, Howe D, Lin CK, Sun J, Ringwald J, Strasser EF, Eckstein R, Seltsam A, Perseghin P, Proserpio P, Wakamoto S, Akino M, Takamoto S, Tadokoro K, Teo D, Shu PH, Chua SS, Jimenez-Marco T, Lozano M, Cid J, Castro E, Muñoz I, Gulliksson H, Sandgren P, Thomas S, Petrik J, McColl K, Kamel H, Dugger J, Sweeney JD, Gorlin JB, Sutor LJ, Heath D, Sayers MH.
Vox Sang. 2015 Jan;108(1):96-100. PMID: 25234238

Differences in the clinical course of heparin induced thrombocytopenia before and after the availability of HIT IgG class testing.
Reagan JL, Ingham RR 2nd, Dalia S, Butera JN, Sweeney JD.
Thromb Res. 2014 Jul;134(1):90-2. PMID: 24830900

Residual plasma in red blood cells and transfusion-related acute lung injury.
Weber LL, Roberts LD, Sweeney JD.
Transfusion. 2014 Oct;54(10):2425-30. PMID: 24762170